Loading...
XNAS
COSM
Market cap12mUSD
Dec 05, Last price  
0.46USD
1D
-6.94%
1Q
-28.88%
Jan 2017
-97.75%
IPO
-98.51%
Name

Cosmos Health Inc

Chart & Performance

D1W1MN
XNAS:COSM chart
P/E
P/S
0.23
EPS
Div Yield, %
Shrs. gr., 5y
104.84%
Rev. gr., 5y
6.53%
Revenues
54m
+1.97%
0000902,3697,639,022533,8026,755,43630,013,37837,083,88239,676,38555,406,33756,239,66750,347,65253,376,87454,426,402
Net income
-16m
L-12.73%
-4,600-3,788,229-169,245-455246,5926,044,691-6,687,912-601,002-6,209,768-9,060,658-3,298,965820,786-7,961,649-13,830,371-18,542,654-16,183,018
CFO
-8m
L-50.65%
0-69,602-87,28931831,4006,525,625-497,089-2,126,081-8,760,141-1,555,306-4,788,842-11,501,718-7,097,174-14,870,639-15,635,999-7,717,034

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Cosmos Health Inc. operates as a vertically integrated pharmaceutical company. It offers a proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, health care and baby products, medical devices, and other products through its distribution channels and an ecommerce marketplace. The company identifies, acquires, develops, and commercializes products that enhance patients' lives and outcomes, as well as has distribution centers in Greece and the United Kingdom; and operates a warehousing facility. It serves wholesale pharmaceutical distributors and independent retail pharmacies. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.
IPO date
May 19, 2010
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT